UK renal registry 17th annual report: Chapter 8 biochemical variables amongst UK adult dialysis patients in 2013: National and centre-specific analyses

Nephron

Volumn 129, Issue , 2015, Pages 169-208

  Shaw, Catriona ^a   Nicholas, Johann ^b   Pitcher, David ^a   Dawnay, Anne ^c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bicarbonate; Biochemical variables; Calcium; Dialysis; Haemodialysis; Parathyroid hormone; Peritoneal dialysis; Phosphate; Quality improvement

Indexed keywords

BICARBONATE; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; MEDICAL AUDIT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM; COHORT ANALYSIS; REGISTER; RENAL REPLACEMENT THERAPY;

ADULT; COHORT STUDIES; GREAT BRITAIN; HUMANS; REGISTRIES; RENAL DIALYSIS;

EID: 84940912473     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000370278     Document Type: Review

References (18)

1. Renal Association: Clinical Practice Guidelines. 5th Edition. http://www. renal.org/Clinical/GuidelinesSection/Guidelines.aspx
2. Ansell D, Tomson CRV: Chapter 15 UK Renal Registry Annual Report: UK Renal Registry, UKRR database, validation and methodology. Nephron Clin Pract. 2009;111(Suppl 1):c277-85
3. Steddon S, Sharpes E: Renal Association Clinical Practice Guideline. CKD-Mineral and Bone Disorders, 2010. http://www.renal.org/ guidelines/modules/ckd-mineral-and-bone-disorders
4. Morton AR, Garland JS, Holden RM: Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial. 2010;23(3): 283-289
5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney International 2009; 76(Suppl 113): S1-S130
6. Spiegelhalter DJ: Funnel plots for comparing institutional performance. Statistics in Medicine 2005;24:1185-1202
7. Mactier R, Hoenich N, Breen C: Renal Association Clinical Practice Guideline Haemodialysis, 2009. http://www.renal.org/Clinical/Guidelines Section/Haemodialysis.aspx
8. Woodrow G, Davies S: Renal Association Clinical Practice Guideline Peritoneal Dialysis, 2010. http://www.renal.org/Clinical/Guidelines Section/PeritonealDialysis.aspx
9. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780
10. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and pth and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 2006;70:351-357
11. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT: The kidney disease outcomes quality initiative (k/doqi) guideline for bone metabolism and disease in ckd: Association with mortality in dialysis patients. Am J Kidney Dis 2005;46:925-932
12. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004;15:770-779
13. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218
14. Danese MD, Belozeroff V, Smirnakis K, Rothman KJ: Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008;2:2
15. Ansell D, Tomson CRV: Twelfth Annual Report: Chapter 10 Biochemistry Profile of Patients Receiving Dialysis in the UK in 2008: National and centre-specific analyses. Bristol, UK Renal Registry, 2009
16. Almond A, Ellis AR, Walker SW: Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Ann Clin Biochem 2011;49:63-67
17. Garrett G, Goldsmith DJA: Parathyroid hormone measurements, guidelines statements and clinical treatments: A real world cautionary tale. Ann Clin Biochem 2011;49:4-6
18. SturgeonCM, SpragueSM,MetcalfeW:Variation in parathyroid hormone immunoassay results - A critical governance issue in the management of chronic kidney disease. Nephrol Dial Transplant 2011;26:3440-3445